BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-027 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-027@nextconsensus.com
DTSTAMP:20261006T000000Z
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261126
SUMMARY:FF-027 deadline: Venglustat · type 3 Gaucher disease approval
DESCRIPTION:Registered forecast FF-027 (FDA)\, Venglustat · type 3 Gaucher
  disease approval. It asks whether this happens by 2026-11-25. The record:
  https://nextconsensus.com/forecast/ff-027/
URL:https://nextconsensus.com/forecast/ff-027/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR